Contact - Lysosomal Disease Network

Breaking News
Updates
Indications Newsletter
Calendar of Events
Contact

Home
About
- LDN Member Sites
Research
- LDN Research Progress Report
- LISA
Resources
Blog

Home
About
- LDN Member Sites
Research
- LDN Research Progress Report
- LISA
Resources
Blog

Lysosomal Disease Network / Contact

Your Name (required)

Your Email (required)

Please leave this field empty.

Your Message

Lysosomal Disease Network
420 Delaware Street SE
MMC 446
Minneapolis, MN 55455
info@nulllysosomaldiseasenetwork.org

Follow us on Twitter: @ldned

Contact Information

Lysosomal Disease Network
420 Delaware Street SE
MMC 446
Minneapolis, MN 55455
info@nulllysosomaldiseasenetwork.org

Chester B. Whitley, PhD, MD
Principal Investigator,
Lysosomal Disease Network
Professor, Dept. of Pediatrics
University of Minnesota,
Twin Cities

David CC Erickson
Informatics Director,
Webmaster
Lysosomal Disease Network

James C. Cloyd, PharmD
Co-Principal Investigator,
Lysosomal Disease Network

Brenda Diethelm-Okita, MPA
Program Manager,
Lysosomal Disease Network

Additional Links

Wikipedia Information Links
NIH Rare Diseases Clinical Research Network

Lysosomal Disease Information

National Institutes of Health
NIH home page
Official List of LDN Projects

Academic Resources
Research Article Database called PubMed, from the National Institute of Health's U.S. National Library of Medicine

Recent Posts

New! Rare Disease Caregiver Respite Program June 28, 2019
The 2019 Sue Rosenau Legacy Award Winner! May 30, 2019
Enroll In the LDN’s Gaucher Disease Research Study October 19, 2018
Progress Towards Clinical Trial for Treatment of MPS IIIC August 28, 2018
Young Investigator Awards are Open for Applications! July 2, 2018

RDCRN-NCATS
©2017 Lysosomal Disease Network

The Lysosomal Disease Network (U54NS065768) is a part of the National Institutes of Health (NIH) Rare Diseases Clinical Research Network (RDCRN), supported through collaboration between the NIH Office of Rare Diseases Research (ORDR) at the National Center for Advancing Translational Science (NCATS), the National Institute of Neurological Disorders and Stroke (NINDS) and National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).